Wayfair walks into its May 21 Q1 earnings release with a bruised stock, a defensive options market, and an analyst community that has spent the past three weeks cutting targets — a setup that frames the print as a test of whether the bull case still has legs.
The Street's posture has turned decidedly cautious on price, even as conviction on the direction of the stock hasn't fully broken. Nearly every firm that responded to the April 30 Q4 report trimmed their target — UBS, Wells Fargo, Guggenheim, Canaccord, Evercore and Mizuho all lowered numbers, in most cases by $10–$25, while maintaining Buy or Outperform ratings. Citigroup did the same this week, cutting from $110 to $95 while keeping its Buy. The mean target now sits at $93.43, implying roughly 63% upside from the $57.40 close — but that gap reflects where the stock has fallen, not where analysts have moved to. TD Cowen and RBC are more cautious, sitting at $75 and $76 respectively with Hold and Sector Perform ratings. The broad message: bulls still believe in the recovery thesis, but the timeline has been pushed out and the entry price keeps repricing lower.
Options positioning echoes the anxiety. The put/call ratio hit 1.46 on May 19 — the highest level of the past 52 weeks, running nearly 3.6 standard deviations above its 20-day average of 0.53. That is not a gradual drift toward caution; the PCR had been range-bound between 0.40 and 0.48 for weeks before spiking on the final session before the print. Investors are paying heavily for downside protection heading into a release where the prior comparable quarter sent the stock down 10.6% in one day and 9.6% over the following five. As previously noted in the May 20 earnings preview, availability in the lending market remains loose at 929% — far above the 52-week low of 316% — with borrow cost a negligible 0.54%. The options market is defensive; the equity lending market is not.
Short interest tells a similarly contradictory story. At 15.6% of the free float, the headline level is elevated — but the direction of travel is meaningfully lower. Short sellers shed nearly 10% of their position over the past month, with the sharpest reduction coming in late April when the float fell from roughly 18.4% to 16.9% in a single week. The ORTEX short score has also drifted down from a peak of 58.7 on May 8 to 54.8, consistent with bears reducing rather than adding exposure ahead of the catalyst. The structure here is a sizeable but shrinking short book, combined with a loose lending market — not the anatomy of a squeeze, but equally not a crowded bearish consensus.
Founder selling adds another layer of context. Both co-founders — CEO Niraj Shah and Co-Chairman Steven Conine — executed sales on April 23 and 24, with Shah selling approximately 26,000 shares and Conine selling roughly 24,000 shares across multiple transactions, at prices in the $76–$79 range. The combined net insider position over the 90 days to April 24 shows net selling of a nominal $21.5 million. The sales were conducted at prices materially above where the stock trades today, meaning the founders were reducing exposure ahead of — not into — the recent decline. JP Morgan Asset Management stood out on the institutional side, adding roughly 2.3 million shares by April 30, a meaningful new position that represents a contrarian bet against the broader negative momentum.
The forward EPS growth ranking at the 93rd percentile is one legitimate bright spot in the factor scores. It suggests the earnings estimate revisions cycle, while negative near-term, still prices in meaningful multi-year recovery. EPS surprise, at the 3rd percentile, is the counterweight — the company has consistently missed, which is part of why the options market treats each print as a risk event rather than a formality. Peers are providing little comfort this week: CVNA fell 14% on the week and REAL dropped 4%, suggesting the broader discretionary space is under pressure, not just Wayfair.
The May 21 print is therefore less about whether Wayfair's recovery thesis is intact and more about whether management can deliver any upside surprise on gross margin and EBITDA that justifies the gap between a $57 stock and a $93 consensus target.
See the live data behind this article on ORTEX.
Open W on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
